S
Susanne K. Kjaer
Researcher at University of Copenhagen
Publications - 674
Citations - 41997
Susanne K. Kjaer is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 90, co-authored 636 publications receiving 36979 citations. Previous affiliations of Susanne K. Kjaer include Copenhagen University Hospital & McGill University.
Papers
More filters
Journal ArticleDOI
Chapter 5: Updating the natural history of HPV and anogenital cancer.
TL;DR: The major steps in cervical carcinogenesis include infection of the metaplastic epithelium of the cervical transformation zone with one or more of the 12-18 carcinogenic types of human papillomavirus (HPV) infection, viral persistence, clonal progression of the persistently-infected epithelia to cervical precancer, and invasion.
Journal ArticleDOI
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study
Susanne K. Kjaer,Adriaan J. C. van den Brule,Gerson Paull,Edith I. Svare,Mark E. Sherman,Birthe Lykke Thomsen,Mette Suntum,Johannes E. Bock,Poll P,Chris J.L.M. Meijer +9 more
TL;DR: Infection with human papillomavirus precedes the development of low and high grade squamous intraepithelial lesions and for high grade lesions the risk is greatest in women positive for the same type of HPV on repeated testing.
Journal ArticleDOI
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Roberta B. Ness,Daniel W. Cramer,Marc T. Goodman,Susanne K. Kjaer,Kathy Mallin,Berit Jul Mosgaard,David M. Purdie,Harvey A. Risch,Ronald Vergona,Anna H. Wu +9 more
TL;DR: Data suggest a role for specific biologic causes of infertility, but not for fertility drugs in overall risk for ovarian cancer, as suggested in case-control studies conducted between 1989 and 1999.
Journal ArticleDOI
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
Joakim Dillner,Joakim Dillner,Susanne K. Kjaer,Cosette M. Wheeler,Kristjan Sigurdsson,Ole Erik Iversen,Mauricio Hernández-Ávila,Gonzalo Perez,Darron R. Brown,Laura A. Koutsky,Eng Tay,Patricia J. Garcia,Kevin A. Ault,Suzanne M. Garland,Sepp Leodolter,Sven Eric Olsson,Grace W.K. Tang,Daron G. Ferris,Jorma Paavonen,Matti Lehtinen,Marc Steben,F. Xavier Bosch,Elmar A. Joura,Slawomir Majewski,Nubia Muñoz,Evan R. Myers,Luisa L. Villa,Frank J. Taddeo,Christine C. Roberts,Amha Tadesse,Janine T. Bryan,Roger Maansson,Shuang Lu,Scott Vuocolo,Teresa M. Hesley,Eliav Barr,Richard M. Haupt +36 more
TL;DR: Quadrivalent HPV vaccine provided sustained protection against low grade lesions attributable to vaccine HPV types and a substantial reduction in the burden of these diseases through 42 months of follow-up.
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Marie-Claude Boily,Hammad Ali,Louise Baandrup,Simon Beddows,Jacques Brisson,Julia M.L. Brotherton,Teresa Cummings,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Philippe Lemieux-Mellouki,Lauri E. Markowitz,Aminata Mboup,David Mesher,Linda M. Niccolai,Jeannie Oliphant,Kevin G.J. Pollock,Kate Soldan,Pam Sonnenberg,Sepehr N. Tabrizi,Clare Tanton,Marc Brisson +28 more
TL;DR: A systematic review and meta-analysis to assess the population-level consequences and herd effects after female HPV vaccination programs, to verify whether or not the high efficacy reported in randomised controlled clinical trials are materialising in real-world situations is materializing in realworld situations.